All posts by: Michael Zand

About Michael Zand

Meissa Vaccines Appoints Dr. Lawrence Blatt as Chairman of the Board of Directors – PR Newswire (press release)

Continue reading

2018-03-13 NEWS

Meissa Vaccines Appoints Dr. Lawrence Blatt as Chairman of the Board of Directors
PR Newswire (press release)
Meissa’s breakthrough technology platform utilizes synthetic biology and reverse genetics to create safer and more effective vaccines. The company is developing vaccines for RSV, parainfluenza virus, human metapneumovirus, and rhinovirus. RSV is a

Continue reading

2018-03-13 NEWS

Genetic Literacy Project

Human testing on beta thalassemia patients: CRISPR readied for …
Genetic Literacy Project
esearchers demonstrated how a gene editing technique, known as Crispr-Cas9, could be used to edit living human cells, raising the possibility that a person’s DNA could be altered much as text is changed by a word-processor. Now, two biotech companies
The next generation of CRISPR-Cas9 begins | The StudentThe Student
Potential Sickle Cell Disease Treatment Seen in Use of Gene …Sickle Cell Anemia News
The future is now: Editing DNA to treat diseaseKSL.com
PLoS Blogs (blog) –Now. Powered by Northrop Grumman. (blog)
all 8 news articles »